Related Experiment Video
Updated: May 26, 2026
17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Methylmercury: a potential environmental risk factor contributing to epileptogenesis
1Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA. yuanyuku@msu.edu.
Neurotoxicology
|December 31, 2011
Summary
Methylmercury (MeHg) exposure, particularly during development, may increase seizure susceptibility. This neurotoxicant might disrupt brain signaling, potentially contributing to epilepsy development.
Area of Science:
- Neuroscience
- Toxicology
- Environmental Health
Background:
- Epilepsy is a common neurological disorder with largely unknown causes.
- Gene-environment interactions are crucial in epilepsy etiology.
- Environmental chemical exposure is a significant risk factor.
Purpose of the Study:
- To review the effects of methylmercury (MeHg) exposure on seizure susceptibility.
- To discuss the role of low-level MeHg exposure in epileptogenesis.
- To explore potential mechanisms of MeHg-induced seizures.
Main Methods:
- Literature review focusing on MeHg and epilepsy.
- Analysis of studies on acute and chronic MeHg poisoning.
- Examination of developmental MeHg exposure effects.
Main Results:
- MeHg is a neurotoxicant targeting the central nervous system.
- MeHg exposure, especially developmental, increases seizure susceptibility in humans and animals.
- Low-level MeHg exposure may contribute to epileptogenesis.
Conclusions:
- MeHg exposure is linked to increased seizure susceptibility.
- Disruption of the GABAergic system by MeHg may lead to disinhibition of glutamatergic function.
- MeHg's impact on neurotransmitter systems could be a mechanism for MeHg-induced epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...